| Year |
Citation |
Score |
| 2012 |
Hegde GV, Nordgren TM, Munger CM, Mittal AK, Bierman PJ, Weisenburger DD, Vose JM, Sharp JG, Joshi SS. Novel therapy for therapy-resistant mantle cell lymphoma: multipronged approach with targeting of hedgehog signaling. International Journal of Cancer. Journal International Du Cancer. 131: 2951-60. PMID 22511234 DOI: 10.1002/Ijc.27602 |
0.728 |
|
| 2012 |
Munger CM, Hegde GV, Weisenburger DD, Vose JM, Joshi SS. Optimized adoptive T-cell therapy for the treatment of residual mantle cell lymphoma. Cancer Immunology, Immunotherapy : Cii. 61: 1819-32. PMID 22441656 DOI: 10.1007/S00262-012-1229-1 |
0.736 |
|
| 2010 |
Nordgren, TM, Hegde G, Munger C, Vose JM, Joshi S. Targeting the PI3K/AKT/Survivin Pathway with Ritonavir In Therapy-Resistant Mantle Cell Lymphoma Blood. 116: 2855-2855. DOI: 10.1182/Blood.V116.21.2855.2855 |
0.717 |
|
| 2008 |
Hegde GV, Munger CM, Emanuel K, Joshi AD, Greiner TC, Weisenburger DD, Vose JM, Joshi SS. Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma. Molecular Cancer Therapeutics. 7: 1450-60. PMID 18524848 DOI: 10.1158/1535-7163.Mct-07-2118 |
0.732 |
|
| 2008 |
Hegde GV, Nordgren TM, Munger CM, Mittal AK, Bierman PJ, Weisenburger DD, Sharp G, Vose JM, Joshi S. Characterization and Novel Treatment for Therapy-Resistant Mantle Cell Lymphoma Isolated from Liver and Kidney Blood. 112: 2622-2622. DOI: 10.1182/Blood.V112.11.2622.2622 |
0.755 |
|
| 2007 |
Joshi AD, Clark EM, Wang P, Munger CM, Hegde GV, Sanderson S, Dave HP, Joshi SS. Immunotherapy of human neuroblastoma using umbilical cord blood-derived effector cells. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 2: 202-12. PMID 18040845 DOI: 10.1007/S11481-006-9038-Y |
0.74 |
|
| 2007 |
Joshi SS, Munger CM, Hegde GV, Weisenburger DD, Vose JM. Therapeutic Effectiveness of Adaptive T-Cell Transfer for Minimal Residual Mantle Cell Lymphoma Following High Dose Therapy. Blood. 110: 2760-2760. DOI: 10.1182/Blood.V110.11.2760.2760 |
0.728 |
|
| 2007 |
Hegde G, Munger C, Emanuel K, Weisenburger D, Joshi A, Vose J, Joshi S. Targeting Conic Hedgehog-GLI Signaling for the Treatment of Mantle Cell Lymphoma Clinical Immunology. 123: S109. DOI: 10.1016/J.Clim.2007.03.490 |
0.692 |
|
| 2006 |
Munger CM, Vose JM, Joshi SS. Dendritic cell-based therapy for mantle cell lymphoma. International Journal of Oncology. 28: 1337-43. PMID 16685434 DOI: 10.1016/J.Clim.2007.03.489 |
0.711 |
|
| 2006 |
Hegde GV, Emanuel K, Joshi AD, Munger CM, Weisenburger DD, Vose JM, Joshi SS. Sonic Hedgehog Signaling in Mantle Cell Lymphoma. Blood. 108: 2046-2046. DOI: 10.1182/Blood.V108.11.2046.2046 |
0.731 |
|
| 2005 |
Sang H, Pisarev VM, Chavez J, Robinson S, Guo Y, Hatcher L, Munger C, Talmadge CB, Solheim JC, Singh RK, Talmadge JE. Murine mammary adenocarcinoma cells transfected with p53 and/or Flt3L induce antitumor immune responses. Cancer Gene Therapy. 12: 427-37. PMID 15678151 DOI: 10.1038/Sj.Cgt.7700809 |
0.471 |
|
| 2004 |
Wang P, Munger CM, Joshi AD, Pirruccello SJ, Joshi SS. Cytotoxicity of cord blood derived Her2/neu-specific cytotoxic T lymphocytes against human breast cancer in vitro and in vivo. Breast Cancer Research and Treatment. 83: 15-23. PMID 14997051 DOI: 10.1023/B:Brea.0000010688.55353.A8 |
0.687 |
|
| 2003 |
Sang H, Pisarev VM, Munger C, Robinson S, Chavez J, Hatcher L, Parajuli P, Guo Y, Talmadge JE. Regional, but not systemic recruitment/expansion of dendritic cells by a pluronic-formulated Flt3-ligand plasmid with vaccine adjuvant activity Vaccine. 21: 3019-3029. PMID 12798646 DOI: 10.1016/S0264-410X(03)00143-9 |
0.307 |
|
| Show low-probability matches. |